MedTrace Logo

Pilot Study to Characterize the Endometriosis Steroidome and Its Link to Endocrine Disruptors and Vaginal Dysbiosis

NCT06820450 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2025-05-29

No results posted yet for this study

Summary

Endometriosis is a systemic, steroid-dependent, inflammatory disease characterized by the growth of endometrial-like tissue outside the uterus, affecting approximately 10 % of women of childbearing age. The etiology and pathophysiology of endometriosis is not completely understood to support effective treatment and prevention strategies. Despite the steroid dependency, little is known concerning the underlying metabolism of estrogen and other tightly related steroids. Moreover, shortening the long diagnostic delays is a major priority in endometriosis research.

Conditions

  • Endometriosis

Interventions

OTHER

Blood test

A blood test (2 x 5 ml dry tubes) will be taken to analyze steroid profiles

OTHER

urine sample

a 20 ml urine sample will be taken to analyze steroid profiles

OTHER

vaginal sample

to characterize the microbiota.

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-15
Primary Completion
2026-03-15
Completion
2027-03-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06820450 on ClinicalTrials.gov